|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011.
|
|
2
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006.
|
|
3
|
Shi Y and Zhou Y: The role of surgery in
the treatment of gastric cancer. J Surg Oncol. 101:687–692.
2010.
|
|
4
|
Leon SA, Shapiro B, Sklaroff DM and Yaros
MJ: Free DNA in the serum of cancer patients and the effect of
therapy. Cancer Res. 37:646–650. 1977.
|
|
5
|
Hanash SM, Baik CS and Kallioniemi O:
Emerging molecular biomarkers - blood-based strategies to detect
and monitor cancer. Nat Rev Clin Oncol. 8:142–150. 2011.
|
|
6
|
Kohler C, Barekati Z, Radpour R and Zhong
XY: Cell-free DNA in the circulation as a potential cancer
biomarker. Anticancer Res. 31:2623–2628. 2011.
|
|
7
|
Sharma VK, Vouros P and Glick J: Mass
spectrometric based analysis, characterization and applications of
circulating cell free DNA isolated from human body fluids. Int J
Mass Spectrom. 304:172–183. 2011.
|
|
8
|
Schwarzenbach H, Hoon DS and Pantel K:
Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev
Cancer. 11:426–437. 2011.
|
|
9
|
Jones PA and Baylin SB: The epigenomics of
cancer. Cell. 128:683–692. 2007.
|
|
10
|
Cheung KF, Lam CN, Wu K, et al:
Characterization of the gene structure, functional significance,
and clinical application of RNF180, a novel gene in gastric cancer.
Cancer. 118:947–959. 2012.
|
|
11
|
Qu Y, Dang S and Hou P: Gene methylation
in gastric cancer. Clin Chim Acta. 424:53–65. 2013.
|
|
12
|
Lee TL, Leung WK, Chan MW, et al:
Detection of gene promoter hypermethylation in the tumor and serum
of patients with gastric carcinoma. Clin Cancer Res. 8:1761–1766.
2002.
|
|
13
|
Cheng YY, Yu J, Wong YP, et al: Frequent
epigenetic inactivation of secreted frizzled-related protein 2
(SFRP2) by promoter methylation in human gastric cancer. Br J
Cancer. 97:895–901. 2007.
|
|
14
|
Martinez-Glez V, Franco-Hernandez C,
Gonzalez-Gomez P, et al: DAPK1 promoter hypermethylation in brain
metastases and peripheral blood. Neoplasma. 54:123–126. 2007.
|
|
15
|
Ben Ayed-Guerfali D, Benhaj K, Khabir A,
et al: Hypermethylation of tumor-related genes in Tunisian patients
with gastric carcinoma: clinical and biological significance. J
Surg Oncol. 103:687–694. 2011.
|
|
16
|
Washington K: 7th edition of the AJCC
cancer staging manual: stomach. Ann Surg Oncol. 17:3077–3079.
2010.
|
|
17
|
Xiong HL, Liu XQ, Sun AH, He Y, Li J and
Xia Y: Aberrant DNA methylation of P16, MGMT, hMLH1 and hMSH2 genes
in combination with the MTHFR C677T genetic polymorphism in gastric
cancer. Asian Pac J Cancer Prev. 14:3139–3142. 2013.
|
|
18
|
Wani M, Afroze D, Makhdoomi M, et al:
Promoter methylation status of DNA repair gene (hMLH1) in gastric
carcinoma patients of the Kashmir valley. Asian Pac J Cancer Prev.
13:4177–4181. 2012.
|
|
19
|
Mir MR, Shabir N, Wani KA, et al:
Association between p16, hMLH1 and E-cadherin promoter
hypermethylation and intake of local hot salted tea and sun-dried
foods in Kashmiris with gastric tumors. Asian Pac J Cancer Prev.
13:181–186. 2012.
|
|
20
|
Abbaszadegan MR, Moaven O, Sima HR, et al:
p16 promoter hypermethylation: a useful serum marker for early
detection of gastric cancer. World J Gastroenterol. 14:2055–2060.
2008.
|
|
21
|
Lu XX, Yu JL, Ying LS, et al: Stepwise
cumulation of RUNX3 methylation mediated by Helicobacter pylori
infection contributes to gastric carcinoma progression. Cancer.
118:5507–5017. 2012.
|
|
22
|
Kang GH, Lee S, Cho NY, et al: DNA
methylation profiles of gastric carcinoma characterized by
quantitative DNA methylation analysis. Lab Invest. 88:161–170.
2008.
|
|
23
|
Li WQ, Pan KF, Zhang Y, et al: RUNX3
methylation and expression associated with advanced precancerous
gastric lesions in a Chinese population. Carcinogenesis.
32:406–410. 2011.
|
|
24
|
Sugita H, Iida S, Inokuchi M, et al:
Methylation of BNIP3 and DAPK indicates lower response to
chemotherapy and poor prognosis in gastric cancer. Oncol Rep.
25:513–518. 2011.
|
|
25
|
Yao D, Shi J, Shi B, et al: Quantitative
assessment of gene methylation and their impact on clinical outcome
in gastric cancer. Clin Chim Acta. 413:787–794. 2012.
|
|
26
|
Ksiaa F, Ziadi S, Amara K, Korbi S and
Trimeche M: Biological significance of promoter hypermethylation of
tumor-related genes in patients with gastric carcinoma. Clin Chim
Acta. 404:128–133. 2009.
|
|
27
|
Hiraki M, Kitajima Y, Koga Y, et al:
Aberrant gene methylation is a biomarker for the detection of
cancer cells in peritoneal wash samples from advanced gastric
cancer patients. Ann Surg Oncol. 18:3013–3019. 2011.
|
|
28
|
Banzai C, Nishino K, Quan J, Yoshihara K,
Sekine M, Yahata T and Tanaka K; Gynecological Cancer Registry of
Niigata. Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A
genes in cervical carcinoma. Int J Clin Oncol. 19:127–132.
2014.
|
|
29
|
Kilinc D, Ozdemir O, Ozdemir S, Korgali E,
Koksal B, Uslu A and Gultekin YE: Alterations in promoter
methylation status of tumor suppressor HIC1, SFRP2, and DAPK1 genes
in prostate carcinomas. DNA Cell Biol. 31:826–832. 2012.
|
|
30
|
Ogawa M, Mizugishi K, Ishiguro A, et al:
Rines/RNF180, a novel RING finger gene-encoded product, is a
membrane-bound ubiquitin ligase. Genes Cells. 13:397–409. 2008.
|
|
31
|
Tamura G: Alterations of tumor suppressor
and tumor-related genes in the development and progression of
gastric cancer. World J Gastroenterol. 12:192–198. 2006.
|
|
32
|
Kinoshita T, Nomoto S, Kodera Y, Koike M,
Fujiwara M and Nakao A: Decreased expression and aberrant
hypermethylation of the SFRP genes in human gastric cancer.
Hepatogastroenterology. 58:1051–1056. 2011.
|
|
33
|
Nojima M, Suzuki H, Toyota M, et al:
Frequent epigenetic inactivation of SFRP genes and constitutive
activation of Wnt signaling in gastric cancer. Oncogene.
26:4699–4713. 2007.
|
